Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Breast Cancer

Gastrointestinal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Colorectal Cancer

Tailored Approaches Offer Curative Potential to CRC Subsets

Michael J. Overman, MD, discusses an immunotherapy combination regimen in metastatic colorectal cancer and highlights existing challenges that still need to be addressed in future research.
Read More >>

Targeted Treatments Usher in Individualized Care in mCRC

Molecular Markers Gaining Greater Influence in CRC Paradigm

NCCN 2019: Testing, Treatment Options Added to NCCN CRC Guidelines

Key Trials Seek to Expand on Efficacy, Tolerability of Treatment Regimens in Refractory CRC

GI Oncologist Sheds Light on Present and Future of mCRC Treatment

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Wisconsin

2019 European Lung Cancer Congress

2019 NCCN Annual Conference

2019 State of the Science Summit on Hematologic Malignancies

2019 SGO Annual Meeting

Dr. Overman on Unmet Needs With Immunotherapy in mCRC

Dr. Fakih on Immunotherapy in MSS Colon Cancer

Dr. Lee on Treatment of Newly Diagnosed mCRC

Dr. Mahipal on Maintenance Therapy in CRC

Dr. Fakih on the Use of Regional Therapy in Colorectal Cancer

Dr. Marshall on HER2 Amplification in Colorectal Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Improving Care for Patients With Colon/Rectal Cancer

Neoadjuvant Strategies for Rectal Cancer

Adjuvant Therapy for High-Risk Colon Cancer

Patient Stratification in Colon Cancer: ctDNA

Adjuvant Therapy for Early-Stage Colon Cancer

$Relapsed/Refractory mCRC: Treatment Dosing Strategies$

$Treatment Recommendations for Relapsed/Refractory mCRC$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Metastatic CRC: Moving Into the Future

Precision Medicine Further Explored in Metastatic CRC

Immunotherapy in MSS Colorectal Cancer

Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC

Significance of MSI Status and TMB in Metastatic CRC

Triplet Regimens in BRAF-Mutant Metastatic CRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Video

Novel Combination Approaches for Metastatic Kidney Cancer